Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.

Slides:



Advertisements
Similar presentations
Development of Service Frameworks June What is a Service Framework? Explicit standards on prevention, treatment and care; Quality requirements supporting.
Advertisements

Referral guidelines for suspected cancer
Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September How useful is the Cancer Waiting Times (CWT) dataset.
National Prostate Cancer Audit Julie Nossiter, Project Manager Clinical Effectiveness Unit – Royal College of Surgeons.
NPCA data submission and reporting
Reinventing Cancer Support Ciarán Devane Chief Executive.
Chameleon Information Management Services Ltd NPCA Update from InfoFlex Sarah Waters Director of New Business.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Trust Cancer Lead Clinician
National Cancer Registry Luxembourg EUROCHIP-3 Meeting Ispra, 27 th February 2012 Olivier Collignon, PhD, Sophie Couffignal, MD, CRP-Santé.
Somerset Cancer Register National Prostate Cancer Audit Conference 5 th December 2014 Ruth McCarthy & Tony Clarke © 2014 Taunton & Somerset NHS Foundation.
The LCA: Implementing a Quality Assurance and Informatics Strategy to Enhance Cancer Care Dr Shelley Dolan LCA Clinical Director.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
Children and Young People Improving Outcomes Guidance  Key aims of guidance and age specific requirements  Designation of Principal Treatment Centres.
ISB Notice and preparing for the implementation of the new IAPT Data Standard Shaun Crowe Mental Health, Employment and IAPT Mental Health Collaborative.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Waiting times for radiotherapy: variation over time and between cancer networks in southeast England David Robinson, Tom Massey & Henrik Møller Thames.
National Cancer Survivorship Initiative Central Hall, Westminster Monday 21 September 2009 Assessment and Care Planning.
Visioning the Quality Performance Indicator (QPI) Reporting Programme Dr Bob Masterton Chair National Cancer Quality Steering Group.
Analysis of Patient Experience of Cancer Care Pathway within Merseyside & Cheshire Produced by Merseyside and Cheshire Cancer Network Presented: November.
Our Service in 10 Mins Claire Ikwan-McCabe Acute Oncology Nurse Friday, 19th April 2013.
The Health Roundtable Improving data collection rates, while improving quality Presenter: Sandra Avery Liverpool Innovation Poster Session HRT1215 – Innovation.
PREPARED BY Faster Cancer Treatment Improving Quality of Care Across the Patient Cancer Pathway John Childs June 2012.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.
NECN Colorectal NSSG Audit of Waiting Times for Lower GI Cancer Patients in NECN April 2010 – March 2011.
Croydon Health Services Paperlite GP Referrals – Using the Service Provider Functionality within ICE Croydon Healthcare NHS Trust is using the Service.
Monitoring the National Cancer Standards for dummies…… ……….by dummies Louise Carrington. Programme Co-ordinator CSCG Andrew Graham. HSW.
Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.
I’m not just a child. I’m a daughter. I’m a son. I’m also a friend, a parent, a wife, a husband…
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
Network Patient Satisfaction Survey Gloria Payne, Patient & Carer Involvement Facilitator Ian Connolly, Performance Improvement Manager Lead Nurse Open.
Cancer Information Framework Initial feedback on NWCN LUCADA submission 2006 data Wednesday 20 th February, 2008 Linda Roberts, Cancer Information Specialist,
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
Carlos Rocha Registry Manager National Cancer Registration Service (South West) West Dean Registration Improvement of Non-Melanoma skin cancer.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
Cancer Outcomes and Services Dataset What is COSD? Implications for Providers and Networks.
Facilitating tissue collection for translational research Jane Rogan Business Manager.
What data are collected? How, and who by? Karen Graham and Barry Plewa.
NCIN Roadshow: Cancer Data NCIN - Cancer Data Roadshow Public Health England | 2015 Elsita Payne Head of Registration – East Midlands and North West Branches.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
Tumour Streams Eleanor Whitehead CCN Project Manager.
Training for organisations participating in Peer Review of Paediatric Diabetes.
Gynaecological Oncology Patient Pathway Cecile Bergzoll Gynaecological Oncologist Wellington.
Faster Cancer Treatment (FCT) - Improving quality of care across the patient cancer pathway Update Aug 2012.
What data are collected? How, and who by?. It’s complicated… ONS data.
Admissions of a non-admitted Access Policy Specialist Clinics Access Policy Implementation at Peter MacCallum Cancer Centre.
Cheshire and Merseyside Strategic Clinical Networks Local Issues and Challenges 22 nd May 2015.
Genomic Medicine Centre Overview
National Oesophago–Gastric Cancer Audit 2015.
CNC Orientation Forum May 2013
SWAG Cancer Alliance Update
Integrated Performance Report 26 October 2017
SWAG SSG Upper GI Cancer Meeting
West of England Genomic Medicine Centre: Our Progress to Date
Pathway for patients with suspected Breast Cancer
Somerset Cancer Register
Somerset Cancer Register
Early Diagnosis Diagnostics Cancer Waits Survivorship South West Cancer Network 14 November 2014.
SWAG SSG Head and neck Cancer Meeting
SWAG SSG Sarcoma Cancer Meeting
SWAG SSG Lung Cancer Meeting
Impact of 2019 Sarcoma Service specification for Bristol
SWAG SSG Skin Cancer Meeting Wednesday 23rd May Research Report
Chris Wragg, Lead Cancer Scientist, SWGLH
SWAG SSG Skin Cancer Meeting
Pathway for patients with suspected Breast Cancer
Breast Cancer SSG 14th November
Lung Cancer Clinical Advisory Group
Squamous cell carcinoma pathway update
Presentation transcript:

Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN

– The new national cancer dataset – Cancer Outcomes and Services – Aligned with patient management – Proposed and supported by clinicians – Incorporates previous cancer registration dataset – Updated and aligned with other datasets – Clarified definitions of data items, codes and values – Specifies Provider submissions – Compiled by registries from Providers and other sources What is COSD?

Cancer Outcomes and Services Dataset COSD - Structure CENTRAL NERVOUS SYSTEM COLORECTAL CHILDREN,TEENAGERS, YOUNG ADULTS GYNAECOLOGY HAEMATOLOGY HEAD & NECK LUNG SARCOMA SKIN UPPER GI UROLOGY CORE - CANCER REGISTRATION Demographics/Referral/Diagnostics/Diagnosis/Care Plan/Treatment BREAST CANCER WAITS Site specific Clinical and Path Patient pathway referral to treatment

Complete patient pathway – Referral details for all cases, all treatments, Includes palliative and supportive care Additional core data items including – Involvement of Clinical Nurse Specialist, Duration of symptoms (Mandatory for Children,Teenagers,Young Adults (CTYA), Optional for others) All registerable conditions – including in situ bladder, in situ melanoma, benign brain tumours Site specific data – Key site specific clinical items – patient management, site specific stage, stage components of RCPath datasets Includes recurrences – Breast cancers to start with What is different about COSD?

Site specific data – Key site specific clinical items – patient management – Site specific stage – Stage components of RCPath datasets Includes recurrences – Breast cancers to start with What’s different about COSD? (2)

– Monthly submission Current cancer registry feeds expanded to include COSD items 25 working days after diagnosis or treatment Send updates as applicable – Aim for three months to complete initial record (to first treatment) – Final updates to first treatment within 6 months – Further treatments - submit 25 working days after treatment – How to collect in “real time” ? – Clinical ownership/sign off for MDT extract PAS extract Path extract RIS extract What does this mean for Trusts?

MDT Systems Pathology Systems Radiology Systems PAS/HIS Systems Work ongoing with Trusts on Gap Analysis Key sources

Many site specific items are in the National Audit Site Specific coding is required for the first phase of implementation – how complete is this likely to be for Head & Neck Patients (does audit dataset help)? Dataset will be circulated for consideration - looking for volunteers to take forward NECN Minimum Dataset Policy developed to clearly outline responsibilities for collection of mandated datasets NSSGs to be asked to incorporate specific staging or coding protocols detailed in the dataset into clinical guidelines to ensure a consistent approach across the network What does this mean for this group?

Thank You